By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
COVID1.81B93.11%
Other revenue126M6.48%
Respiratory syncytial virus (RSV)8M0.41%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States1.2B61.68%
Rest of world692M35.60%
Europe53M2.73%